Romerike Sparebank (FRA:92I) Research & Development: €0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:92I Romerike Sparebank FRA:92I
55 GF Score
Price €13.80
GF Value €13.12
! 3 Warning Signs
View Full Analysis

What is Romerike Sparebank Research & Development?

Romerike Sparebank FRA:92I 55 Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:92I with a GF Score™ of 55/100 and a GF Value™ of €13.12. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Romerike Sparebank's Research & Development for the three months ended in Mar. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

Romerike Sparebank  (FRA:92I) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Romerike Sparebank Research & Development Related Terms

Romerike Sparebank Research & Development Historical Data

* Premium members only.

The historical data trend for Romerike Sparebank's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Romerike Sparebank Research & Development Chart

Romerike Sparebank Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Romerike Sparebank Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:92I
55GF Score
Romerike Sparebank FRA:92I
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Romerike Sparebank Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Romerike Sparebank (FRA:92I) has a Research & Development of €0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Romerike Sparebank and its competitors.
Is Romerike Sparebank's Research & Development too high?
Romerike Sparebank's current Research & Development is €0.00 Mil. Overall, Romerike Sparebank has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Romerike Sparebank's Research & Development compare to competitors?
Romerike Sparebank's Research & Development of €0.00 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Romerike Sparebank and its competitors. Romerike Sparebank's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Romerike Sparebank stock overvalued right now?
Romerike Sparebank (FRA:92I) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €13.12, compared to a current price of €13.80 — trading 5.2% above its estimated fair value. The current Research & Development is €0.00 Mil. Romerike Sparebank's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Romerike Sparebank (FRA:92I), the current Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Romerike Sparebank (FRA:92I) Overvalued in 2026?

Based on GuruFocus' analysis, Romerike Sparebank stock appears to be overvalued. The current stock price of €13.80 is trading 5.2% above its estimated GF Value™ of €13.12.

Key valuation signals for FRA:92I:

  • Research & Development: €0.00 Mil
  • GF Value™: €13.12 vs. price of €13.80 (5.2% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the FRA:92I stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Romerike Sparebank Business Description

Other Exchanges ROMER:Norway
Address Torvet 5, Lillestrom, NOR, 2000
Romerike Sparebank is a local bank that provides banking and financial services in Norway. It provides services of Daily banking, Insurance, Loans, Savings and Retitement.
55GF Score

Get the complete analysis for FRA:92I

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.80
Price
€13.12
GF Value